Compare Master Print Tbk. (PTMR) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Master Print Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Master Print Tbk. trades at Rp374 (market cap 713.22B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Master Print Tbk. is far larger — about 6.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PTMR | SCPI | |
|---|---|---|
Market Cap | 713.22B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Master Print Tbk.
PT Master Print Tbk (the Company) is a limited liability company established in Jakarta based on Notarial Deed No. 44 of H. Warman, S.H., on May 26, 2006. The parent entity and ultimate holding entity of the Company is PT Mitra Pack Tbk. The Company commenced its commercial operations in 2008.
Read more on PTMR →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
